Malignant peritoneal mesothelioma · 1 regimen
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Atezolizumab and Bevacizumab Variant #01 | — | R 61 241 | 21d | ~11.2 mo | ~19.2 mo | ~2 | ~R 122 482 PFS proxy · indirect | 2 |
1 of 1 regimen shown